At the annual American Society of Hematology meeting, researchers reported that 15 autoimmune disease patients who received CAR-T therapy are still in complete remission. This includes eight lupus patients, four with systemic sclerosis, and three with inflammatory myositis. The success of these results has inspired hope for an emerging field in autoimmune diseases, and there is potential for using CAR-T therapy for other diseases that were not believed to be driven by B lymphocytes or plasma cells. Researchers still have questions about the reproducibility, safety, and long-term efficacy of this therapy.
Source link
CAR-T helps other autoimmune patients in small study
